Tackling challenges of TB/MDRTB in China: concerted actions are imperative
- PMID: 25908975
- PMCID: PMC4407541
- DOI: 10.1186/s40249-015-0050-4
Tackling challenges of TB/MDRTB in China: concerted actions are imperative
Abstract
China is the second largest TB epidemic with the most number of people infected with multi-drug resistant (MDR). Over the past decade, a large number of TB control projects have been funded by the government of China and international organizations, and epidemic in China has been effectively controlled. However TB control in China still faced many challenges. Strategies to address these challenges may include integrating the national TB control program into health insurance schemes, strengthening TB case management through involving the Chinese hospital in national TB control program, and reforming payment methods for TB care as part of health system reform in China.
Keywords: China; Tuberculosis.
Similar articles
-
Multi-source financing for tuberculosis treatment in China: key issues and challenges.Infect Dis Poverty. 2021 Mar 10;10(1):17. doi: 10.1186/s40249-021-00809-4. Infect Dis Poverty. 2021. PMID: 33750460 Free PMC article.
-
What lessons can be drawn from tuberculosis (TB) control in China in the 1990s? An analysis from a health system perspective.Health Policy. 2005 Apr;72(1):93-104. doi: 10.1016/j.healthpol.2004.06.009. Health Policy. 2005. PMID: 15760702
-
[Exogenous re-infection in tuberculosis].Kekkaku. 2006 Feb;81(2):79-91. Kekkaku. 2006. PMID: 16529009 Japanese.
-
[How to cope with the global tuberculosis burden--experiences and perspectives for Japan's international cooperation].Kekkaku. 2005 Feb;80(2):89-94. Kekkaku. 2005. PMID: 15920981 Review. Japanese.
-
[Reform of Japan's NTP and its technical perspectives].Kekkaku. 2004 Oct;79(10):587-604. Kekkaku. 2004. PMID: 15631111 Review. Japanese.
Cited by
-
Influence of Public Health Services on the Goal of Ending Tuberculosis: Evidence From Panel Data in China.Front Public Health. 2022 Mar 4;10:826800. doi: 10.3389/fpubh.2022.826800. eCollection 2022. Front Public Health. 2022. PMID: 35309188 Free PMC article.
-
Challenges Faced by Multidrug-Resistant Tuberculosis Patients in Three Financially Affluent Chinese Cities.Risk Manag Healthc Policy. 2020 Nov 2;13:2387-2394. doi: 10.2147/RMHP.S275400. eCollection 2020. Risk Manag Healthc Policy. 2020. PMID: 33173363 Free PMC article.
-
Multidrug-resistant tuberculosis in rural China: lack of public awareness, unaffordable costs and poor clinical management.BMJ Case Rep. 2018 Aug 11;2018:bcr2018225794. doi: 10.1136/bcr-2018-225794. BMJ Case Rep. 2018. PMID: 30100573 Free PMC article.
-
The impact of increased reimbursement rates under the new cooperative medical scheme on the financial burden of tuberculosis patients.Infect Dis Poverty. 2019 Aug 2;8(1):67. doi: 10.1186/s40249-019-0575-z. Infect Dis Poverty. 2019. PMID: 31370909 Free PMC article.
-
Utilization and expenses of outpatient services among tuberculosis patients in three Chinese counties: an observational comparison study.Infect Dis Poverty. 2019 Oct 4;8(1):79. doi: 10.1186/s40249-019-0590-0. Infect Dis Poverty. 2019. PMID: 31581953 Free PMC article.
References
-
- World Health Organization. Global tuberculosis report 2014. [http://apps.who.int/iris/bitstream/10665/137094/1/9789241564809_eng.pdf?...]
-
- World Health Organization. Drug-resistant tuberculosis--surveillance & response. [http://apps.who.int/iris/bitstream/10665/137095/1/WHO_HQ_TB_2014.12_eng....]
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous